Portfolio company
ArgenX
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Arcellx
This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.
Autolus Therapeutics
This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Hummingbird Bioscience
This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.
AbCellera Biologics
The company develops antibody-based medicines and discovery technologies for pharmaceutical and biotechnology partners to treat cancer, autoimmune disorders and infectious diseases.
Toleranzia
This company develops drugs using an immune tolerance platform to treat patients with rare autoimmune diseases, such as myasthenia gravis.
Viridiantherapeutics
This company develops antibody treatments for patients living with rare autoimmune conditions and thyroid eye disease.
Vor Bio
This biotechnology company develops therapies for patients living with serious autoantibody-driven autoimmune diseases, such as myasthenia gravis and Sjögren's disease.